Certuity LLC Makes New $415,000 Investment in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) : vimarsana.com

Certuity LLC purchased a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,150 shares of the company’s stock, valued at approximately $415,000. A number of other hedge funds also recently modified their […]

Related Keywords

United States , Eric Benevich , Davidw Boyer , Neurocrine Biosciences , Capital Partners , Citigroup , Securities Exchange Commission , Cantor Fitzgerald , Charles Schwab Investment Management Inc , Neurocrine Biosciences Inc , Barclays , Westfield Capital Management Co , Nasdaq , Wells Fargo Company , Jacobs Levy Equity Management Inc , Free Report , Levy Equity Management , Capital Management , Charles Schwab Investment Management , Schwab Investment Management , Get Free Report , Neurocrine Biosciences Daily , Nasdaq Nbix , Nbix , Medical , 64125c10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,